Umezawa Ryohei, Yamada Masanobu, Horiguchi Kazuhiko, Ishii Sumiyasu, Hashimoto Koshi, Okada Shuichi, Satoh Teturou, Mori Masatomo
Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, 3-39-15 Showa-machi, Maebashi, Gunma 371-8511, Japan.
Endocrinology. 2009 Jul;150(7):3425-32. doi: 10.1210/en.2008-1738. Epub 2009 Mar 19.
We reported a novel mutation of thyroid hormone receptor (TR)-beta, F455S, in a patient with pituitary resistance to thyroid hormone (RTH), who showed impaired release of nuclear receptor corepressor and abnormal histone deacetylation. In the present study, we further analyzed the histone modifications and the dynamics of TR and RNA polymerase II on the TRH gene. The lysine residues 9 (H3K9) and 14 (K14) of the histone H3 were acetylated in the absence of thyroid hormone (TH), and addition of TH caused a temporary deacetylation of both residues. Although H3K4 was di- and trimethylated in the absence of T(3), no methylation of H3K9 or K27 was detected. Long-term incubation with T(3) decreased the level of trimethylated H3K4, the amount of TR, and the level of phosphorylated RNA polymerase II but not dimethylated H3K4. Treatment with an inhibitor for H3K4 methyltransferase, 5'-deoxy-5'-methylthioadenosine, decreased basal promoter activity but did not affect the repression by TH. Conversely, overexpression of MLL, an H3K4-specific methyltransferase, caused an increase in basal activity. In the presence of F455S, methylation of H3K4 and the dynamics of TR were intact, but both H3K9 and H3K14 were hyperacetylated, and T(3)-induced deacetylation was impaired, resulting in a high transcriptional level. These findings demonstrated that 1) negative regulation of the TRH gene by TH involves both the acetylation and methylation of specific residues of histone tails and changing the amount of TR, and 2) the major impairment to histone modifications in F455S was hyperacetylation of the specific histone tails.
我们报道了一名垂体性甲状腺激素抵抗(RTH)患者甲状腺激素受体(TR)-β的一种新型突变F455S,该患者表现出核受体共抑制因子释放受损和异常的组蛋白去乙酰化。在本研究中,我们进一步分析了促甲状腺激素释放激素(TRH)基因上的组蛋白修饰以及TR和RNA聚合酶II的动态变化。在无甲状腺激素(TH)的情况下,组蛋白H3的赖氨酸残基9(H3K9)和14(K14)被乙酰化,添加TH导致这两个残基暂时去乙酰化。尽管在无T3的情况下H3K4发生了二甲基化和三甲基化,但未检测到H3K9或K27的甲基化。长期用T3孵育会降低三甲基化H3K4的水平、TR的量以及磷酸化RNA聚合酶II的水平,但不会降低二甲基化H3K4的水平。用H3K4甲基转移酶抑制剂5'-脱氧-5'-甲硫腺苷处理会降低基础启动子活性,但不影响TH的抑制作用。相反,H3K4特异性甲基转移酶MLL的过表达会导致基础活性增加。在存在F455S的情况下,H3K4的甲基化和TR的动态变化是完整的,但H3K9和H3K14均过度乙酰化,且T3诱导的去乙酰化受损,导致转录水平升高。这些发现表明:1)TH对TRH基因的负调控涉及组蛋白尾部特定残基的乙酰化和甲基化以及TR量的变化;2)F455S中组蛋白修饰的主要损伤是特定组蛋白尾部的过度乙酰化。